Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). EJRDI. 2023;26:1-4. Accessed January 30, 2026. https://geniusjournals.org/index.php/ejrdi/article/view/5178